Next Article in Journal
Structure-Guide Design and Optimization of Potential Druglikeness Inhibitors for TGFβRI with the Pyrrolopyrimidine Scaffold
Previous Article in Journal
Identification of Novel Cyanopyridones and Pyrido[2,3-d]Pyrimidines as Anticancer Agents with Dual VEGFR-2/HER-2 Inhibitory Action: Synthesis, Biological Evaluation and Molecular Docking Studies
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(10), 1263; https://doi.org/10.3390/ph15101263
Action Date Notes Link
article xml file uploaded 13 October 2022 15:36 CEST Original file -
article xml uploaded. 13 October 2022 15:36 CEST Update -
article pdf uploaded. 13 October 2022 15:36 CEST Version of Record -
article supplementary file uploaded. 13 October 2022 15:36 CEST - https://www.mdpi.com/1424-8247/15/10/1263#supplementary
article html file updated 13 October 2022 15:37 CEST Original file -
article xml file uploaded 13 October 2022 15:40 CEST Update -
article xml uploaded. 13 October 2022 15:40 CEST Update https://www.mdpi.com/1424-8247/15/10/1263/xml
article pdf uploaded. 13 October 2022 15:40 CEST Updated version of record https://www.mdpi.com/1424-8247/15/10/1263/pdf
article html file updated 13 October 2022 15:42 CEST Update -
article html file updated 28 February 2023 17:56 CET Update -
article html file updated 1 March 2023 21:27 CET Update https://www.mdpi.com/1424-8247/15/10/1263/html
Back to TopTop